Similarly, overactivated P38 has been shown to increase tau phosphorylation and favor amyloidogenic processing of the amyloid precursor protein (APP), while inhibition of JNK by D-JNKI1 is suggested to suppress synaptic shrinkage in AD patients [149,151,152]. Here, APP is linked to Alzheimer disease.